Chapter 16 Detection of SCLC metastic cells in bone marrow by means of the monoclonal antibody MLuC1

S. Menard, G. Porrow, S. Giani, A. Bedini, P. Bidoli, A. Santoro, M. Bregni, A. M. Gianni, S. Pilotti, F. Rilke, S. Soresi, S. Fasolato, M. I. Colnaghi

Research output: Contribution to journalArticle

Abstract

Many monoclonal antibodies (Moabs) have been demonstrated to be useful as diagnostic tools. We investigated the possibility of using Moabs to detect metastatic cells in vitro in the bone marrow from small cell lung carcinoma (SCLC) patients, either for staging the disease or in the perspective of bone marrow transplantation. The monoclonal antibody designated MLuC1 was selected for this application due to its strong and homogeneous reactivity on almost all the tested SCLC and its negativity on normal bone marrow cells. Among 30 bone marrow aspirates obtained from SCLC patients, 4 cases were found to be positive for presence of malignant cells with both conventional histology and immunofluorescence using MLuC1. Among the other histologically negative bone marrow MLuC1 reactive cells were found in 5 cases. The MLuC1-positive cases were monitored during and after chemotherapy and a progressive decrease in the number of bone marrow contaminating tumour cells was observed by MLuC1 immunofluorescence.

Original languageEnglish
Pages (from-to)73-75
Number of pages3
JournalLung Cancer
Volume4
Issue number1-2
DOIs
Publication statusPublished - 1988

Fingerprint

Small Cell Lung Carcinoma
Bone Marrow Cells
Monoclonal Antibodies
Bone Marrow
Fluorescent Antibody Technique
Bone Marrow Transplantation
Histology
Drug Therapy
Neoplasms

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Pulmonary and Respiratory Medicine

Cite this

Chapter 16 Detection of SCLC metastic cells in bone marrow by means of the monoclonal antibody MLuC1. / Menard, S.; Porrow, G.; Giani, S.; Bedini, A.; Bidoli, P.; Santoro, A.; Bregni, M.; Gianni, A. M.; Pilotti, S.; Rilke, F.; Soresi, S.; Fasolato, S.; Colnaghi, M. I.

In: Lung Cancer, Vol. 4, No. 1-2, 1988, p. 73-75.

Research output: Contribution to journalArticle

Menard, S, Porrow, G, Giani, S, Bedini, A, Bidoli, P, Santoro, A, Bregni, M, Gianni, AM, Pilotti, S, Rilke, F, Soresi, S, Fasolato, S & Colnaghi, MI 1988, 'Chapter 16 Detection of SCLC metastic cells in bone marrow by means of the monoclonal antibody MLuC1', Lung Cancer, vol. 4, no. 1-2, pp. 73-75. https://doi.org/10.1016/S0169-5002(88)80018-7
Menard, S. ; Porrow, G. ; Giani, S. ; Bedini, A. ; Bidoli, P. ; Santoro, A. ; Bregni, M. ; Gianni, A. M. ; Pilotti, S. ; Rilke, F. ; Soresi, S. ; Fasolato, S. ; Colnaghi, M. I. / Chapter 16 Detection of SCLC metastic cells in bone marrow by means of the monoclonal antibody MLuC1. In: Lung Cancer. 1988 ; Vol. 4, No. 1-2. pp. 73-75.
@article{92db05a81ba543c7a6c7a583d903339c,
title = "Chapter 16 Detection of SCLC metastic cells in bone marrow by means of the monoclonal antibody MLuC1",
abstract = "Many monoclonal antibodies (Moabs) have been demonstrated to be useful as diagnostic tools. We investigated the possibility of using Moabs to detect metastatic cells in vitro in the bone marrow from small cell lung carcinoma (SCLC) patients, either for staging the disease or in the perspective of bone marrow transplantation. The monoclonal antibody designated MLuC1 was selected for this application due to its strong and homogeneous reactivity on almost all the tested SCLC and its negativity on normal bone marrow cells. Among 30 bone marrow aspirates obtained from SCLC patients, 4 cases were found to be positive for presence of malignant cells with both conventional histology and immunofluorescence using MLuC1. Among the other histologically negative bone marrow MLuC1 reactive cells were found in 5 cases. The MLuC1-positive cases were monitored during and after chemotherapy and a progressive decrease in the number of bone marrow contaminating tumour cells was observed by MLuC1 immunofluorescence.",
author = "S. Menard and G. Porrow and S. Giani and A. Bedini and P. Bidoli and A. Santoro and M. Bregni and Gianni, {A. M.} and S. Pilotti and F. Rilke and S. Soresi and S. Fasolato and Colnaghi, {M. I.}",
year = "1988",
doi = "10.1016/S0169-5002(88)80018-7",
language = "English",
volume = "4",
pages = "73--75",
journal = "Lung Cancer",
issn = "0169-5002",
publisher = "Elsevier Ireland Ltd",
number = "1-2",

}

TY - JOUR

T1 - Chapter 16 Detection of SCLC metastic cells in bone marrow by means of the monoclonal antibody MLuC1

AU - Menard, S.

AU - Porrow, G.

AU - Giani, S.

AU - Bedini, A.

AU - Bidoli, P.

AU - Santoro, A.

AU - Bregni, M.

AU - Gianni, A. M.

AU - Pilotti, S.

AU - Rilke, F.

AU - Soresi, S.

AU - Fasolato, S.

AU - Colnaghi, M. I.

PY - 1988

Y1 - 1988

N2 - Many monoclonal antibodies (Moabs) have been demonstrated to be useful as diagnostic tools. We investigated the possibility of using Moabs to detect metastatic cells in vitro in the bone marrow from small cell lung carcinoma (SCLC) patients, either for staging the disease or in the perspective of bone marrow transplantation. The monoclonal antibody designated MLuC1 was selected for this application due to its strong and homogeneous reactivity on almost all the tested SCLC and its negativity on normal bone marrow cells. Among 30 bone marrow aspirates obtained from SCLC patients, 4 cases were found to be positive for presence of malignant cells with both conventional histology and immunofluorescence using MLuC1. Among the other histologically negative bone marrow MLuC1 reactive cells were found in 5 cases. The MLuC1-positive cases were monitored during and after chemotherapy and a progressive decrease in the number of bone marrow contaminating tumour cells was observed by MLuC1 immunofluorescence.

AB - Many monoclonal antibodies (Moabs) have been demonstrated to be useful as diagnostic tools. We investigated the possibility of using Moabs to detect metastatic cells in vitro in the bone marrow from small cell lung carcinoma (SCLC) patients, either for staging the disease or in the perspective of bone marrow transplantation. The monoclonal antibody designated MLuC1 was selected for this application due to its strong and homogeneous reactivity on almost all the tested SCLC and its negativity on normal bone marrow cells. Among 30 bone marrow aspirates obtained from SCLC patients, 4 cases were found to be positive for presence of malignant cells with both conventional histology and immunofluorescence using MLuC1. Among the other histologically negative bone marrow MLuC1 reactive cells were found in 5 cases. The MLuC1-positive cases were monitored during and after chemotherapy and a progressive decrease in the number of bone marrow contaminating tumour cells was observed by MLuC1 immunofluorescence.

UR - http://www.scopus.com/inward/record.url?scp=0009544184&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0009544184&partnerID=8YFLogxK

U2 - 10.1016/S0169-5002(88)80018-7

DO - 10.1016/S0169-5002(88)80018-7

M3 - Article

AN - SCOPUS:0009544184

VL - 4

SP - 73

EP - 75

JO - Lung Cancer

JF - Lung Cancer

SN - 0169-5002

IS - 1-2

ER -